Search

Illumina Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

193.44 -1.57

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

193.09

Max

195.66

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-200M

134M

Pardavimai

-68M

1.1B

P/E

Sektoriaus vid.

33.886

62.58

Pelnas, tenkantis vienai akcijai

1.15

Pelno marža

12.282

Darbuotojai

8,600

EBITDA

-195M

250M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

-11.83% downside

Dividendai

By Acuity

Kitas uždarbis

2026-07-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

8.4B

28B

Ankstesnė atidarymo kaina

195.01

Ankstesnė uždarymo kaina

193.44

Naujienos nuotaikos

By Acuity

20%

80%

36 / 340 reitingas Healthcare

Illumina Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-24 17:46; UTC

Illumina Inc's shares are lower today, hitting a mid-morning low. Broader market sentiment may be affected by recent volatility in oil prices.

2026-07-22 19:31; UTC

News

Illumina Inc shares are lower amid a report citing stagnant sales and concerns over management's investment opportunities. The company may need acquisitions for growth.

2026-07-21 20:02; UTC

Correlated Moves
News

Illumina Inc's shares are higher, supported by broader market momentum and anticipation of upcoming earnings from major companies. The Russell 2000 Index also advanced.

2026-07-20 19:56; UTC

Correlated Moves

Illumina Inc shares declined during Monday's session, paralleling a drop in the ARK Genomic Revolution ETF amid broader market weakness.

2026-07-17 19:06; UTC

Illumina Inc shares are lower today amid broader market declines, particularly in technology and semiconductor stocks, following significant selling pressure in Asia.

2026-07-16 22:06; UTC

Illumina Inc shares are lower in after-market hours, tracking broader market declines amid geopolitical tensions and mixed economic indicators.

2026-07-15 18:51; UTC

Illumina Inc shares declined Wednesday, pulling back from earlier gains. No specific news was identified to explain this movement amid broader positive market trends.

2026-07-14 19:36; UTC

News

Illumina shares rise as Canaccord raises price target to $190.00, despite a patent ruling against the company in Germany.

2026-07-10 20:06; UTC

Correlated Moves

Illumina Inc shares are lower amid a broader decline in the biotechnology sector. Market volatility is heightened due to geopolitical tensions involving the U.S. and Iran.

2026-07-09 19:11; UTC

News
Correlated Moves

Illumina Inc. appointed Mike Sullivan as Chief Commercial Officer and Julie Coletti as Chief Legal Officer, contributing to a rise in shares amid sector gains.

2026-07-08 20:04; UTC

Correlated Moves

Illumina Inc shares are lower today, influenced by declines in the Life Sciences Tools & Services sector and a drop in the Russell 2000 Index.

2026-07-07 21:41; UTC

Illumina Inc. shares are higher in after-market trading, reflecting ongoing strength despite earlier session pullbacks and broader caution in the technology sector.

2026-07-06 19:52; UTC

Social Media
News

Evercore ISI raised its price target on Illumina to $200, maintaining an Outperform rating. Shares are trading higher amid positive sentiment and social media discussions.

2026-07-02 23:06; UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader trends despite positive movements in European equity indices, including a rise in the DAX.

2026-07-01 20:03; UTC

News

Piper Sandler raised Illumina's price target to $200, contributing to shares trading higher today. The company also expanded its board with a new appointment.

2026-06-30 20:01; UTC

News
Social Media

Illumina Inc shares are lower as Roche launches a competing gene sequencer at a lower price, challenging Illumina's market share in genetic testing technology.

2026-06-29 23:16; UTC

Illumina Inc shares are lower in after-market trading, with no specific news identified to explain the movement. Broader U.S. equities show mixed performance.

2026-06-26 23:16; UTC

Illumina Inc shares are trading lower in after-market hours. Broader market concerns over rising interest rates and inflation may be influencing investor behavior.

2026-06-25 23:26; UTC

Illumina Inc shares are higher in after-market trading, reflecting strong performance above their 20-day moving average despite no specific news driving the move.

2026-06-24 20:02; UTC

News
Social Media

Illumina Inc. shares are higher amid gains in the Life Sciences Tools & Services sector. Barclays raised its price target to $145 from $122.

2026-06-23 22:46; UTC

Illumina Inc shares are higher in after-market trading, reflecting a notable advance since Tuesday's close and strong performance near the upper end of its one-month range.

2026-06-22 19:32; UTC

Illumina Inc's shares are higher today, despite declines in the Nasdaq. The stock remains flat since Thursday, with no specific news driving the movement.

2026-06-19 00:02; UTC

Correlated Moves

Illumina Inc shares are lower in after-market hours, reflecting broader market sentiment as the Russell 2000 Index also declined slightly.

2026-06-18 23:01; UTC

Illumina Inc shares are lower in after-market hours following earlier gains. The stock showed unusual volatility during this session without identifiable news.

2026-06-17 20:03; UTC

Correlated Moves
Macro Event

Illumina Inc shares are lower today, driven by broader market declines and macroeconomic concerns related to the Federal Reserve's monetary policy decisions.

2026-06-16 19:56; UTC

Correlated Moves

Illumina Inc. shares are lower today, following a broader market decline. The stock remains above its 20-day moving average despite recent fluctuations.

2026-06-15 13:02; UTC

Correlated Moves

Illumina Inc shares are higher in pre-market trading, reflecting strong momentum since Friday's close and aligning with the broader Russell 2000 Index trend.

2026-06-12 19:56; UTC

Illumina Inc's shares are lower today, continuing a downward trend since Thursday. The stock remains above its 20-day moving average despite the decline.

2026-06-11 20:03; UTC

Correlated Moves
News

Illumina Inc launched its StrataMap Spatial Solution, enhancing gene detection capabilities. Shares are advancing in Thursday's session, recovering from earlier lows.

2026-06-10 23:11; UTC

Illumina Inc shares are higher in after-market trading, supported by a notable upward trend in the Life Sciences Tools & Services sub-sector.

Akcijų palyginimas

Kainos pokytis

Illumina Inc Prognozė

Kainos tikslas

By TipRanks

-11.83% į apačią

12 mėnesių prognozė

Vidutinis 171.13 USD  -11.83%

Aukščiausias 220 USD

Žemiausias 95 USD

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Illumina Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

15 ratings

8

Pirkti

4

Laikyti

3

Parduoti

Rinkos nuotaikos

By Acuity

36 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat